Since GAL(1–15) also induces a substantial reduction in preference and voluntary alcohol consumption in rats [30] with involvement of the dopaminergic mesolimbic system, which is critical for the reward system [24,30], the combination of GAL(1–15) with ESC could be proposed as an effective treatment for AUD patients with comorbid major depression. This evidence concerns the gene GAL and major depressive disorder.